483
Rio Biofarma Brasil LtdaRio Biofarma Brasil Ltda – FDA 483, Aug 2, 2022
Record Details
An FDA inspection of RIO BIOFARMA BRASIL LTDA, a sterile drug manufacturer in Hortolandia, Brazil, revealed significant deficiencies in aseptic processing controls and quality unit oversight. The firm failed to implement adequate environmental monitoring during sterile operations and did not properly review raw data from chromatography systems. Additionally, laboratory records lacked specifications, leading to unreported out-of-specification results for stability studies.
View Company Profile
ID · a3ce097d-3d9c-47f5-bb8d-02d6db0b5081
Other documents for Rio Biofarma Brasil Ltda
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.